Patent Assignment
Reel/Frame 063433/0437
Assignment of Assignor's Interest
Recorded: 2023-04-25
Pages: 3
Assignor
SHANNON, PATRICK
Executed: 2017-01-24
Assignee
CANCER PREVENTION PHARMACEUTICALS, INC.
1760 E. RIVER ROAD, TUCSON, ARIZONA, 85718
Covered Property
(1)
Eflornithine and Sulindac, Fixed Dose Combination Formulation
Patent:
11,529,326 →
Application:
17/193,588 →
Publication:
US 2021/0267926
PCT:
PCT/US2016/059689 ↗
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 25, 2023
From: DUCASSOU, JEAN
To: SANOFI WINTHROP INDUSTRIE
Reel/Frame 063433/0061 →
Assignment of Assignor's Interest
Apr 25, 2023
From: BRAVO GONZALEZ, ROBERTO CARLOS
To: TILLOTTS PHARMA AG
Reel/Frame 063433/0365 →
Assignment of Assignor's Interest
Apr 25, 2023
From: SANOFI WINTHROP INDUSTRIE S.A.
To: CANCER PREVENTION PHARMACEUTICALS, INC.
Reel/Frame 063433/0591 →
Assignment of Assignor's Interest
Apr 25, 2023
From: TILLOTTS PHARMA AG
To: CANCER PREVENTION PHARMACEUTICALS, INC.
Reel/Frame 063433/0674 →
Assignment of Assignor's Interest
Oct 30, 2025
From: PANBELA THERAPEUTICS, INC.; PANBELA RESEARCH, INC.; CANCER PREVENTION PHARMACEUTICALS, INC.
To: CREATIVE PLANNING BUSINESS ALLIANCE LLC
Reel/Frame 072735/0859 →
Assignment of Assignor's Interest
Nov 3, 2025
From: CREATIVE PLANNING BUSINESS ALLIANCE, LLC
To: USWM, LLC
Reel/Frame 072766/0028 →